• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SCHEDULE 13G filed by Balchem Corporation

    4/29/26 5:10:38 PM ET
    $BCPC
    Major Chemicals
    Industrials
    Get the next $BCPC alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    Balchem Corp

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)




    057665200

    (CUSIP Number)
    03/31/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)




    schemaVersion:


    SCHEDULE 13G

    CUSIP Number(s):
    057665200


    1Names of Reporting Persons

    Vanguard Capital Management
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    PENNSYLVANIA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    248,883.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    1,680,971.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    1,680,971.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.24 %
    12Type of Reporting Person (See Instructions)

    IA

    Comment for Type of Reporting Person:   In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd. This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power. This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Balchem Corp
    (b)Address of issuer's principal executive offices:

    5 Paragon Dr, Montvale, NJ, 07645
    Item 2. 
    (a)Name of person filing:

    Vanguard Capital Management
    (b)Address or principal business office or, if none, residence:

    100 Vanguard Blvd,, Malvern, PA, 19355
    (c)Citizenship:

    PA
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP Number(s):

    057665200
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    1680971
    (b)Percent of class:

    5.24  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    248883

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    1680971

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    Vanguard Capital Management, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Vanguard Capital Management
     
    Signature:Ashley Grim
    Name/Title:Head of Global Fund Administration
    Date:04/29/2026
    Get the next $BCPC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BCPC

    DatePrice TargetRatingAnalyst
    12/5/2025$162.00Neutral
    Rothschild & Co Redburn
    3/8/2022$170.00 → $155.00Buy
    HC Wainwright & Co.
    2/22/2022$175.00Neutral → Buy
    Sidoti
    1/10/2022$160.00 → $170.00Buy
    HC Wainwright & Co.
    11/29/2021$175.00Buy → Neutral
    Sidoti
    8/2/2021$140.00 → $145.00Overweight → Equal-Weight
    Stephens & Co.
    8/2/2021$145.00 → $160.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $BCPC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Gilson Erin Leigh

    3 - BALCHEM CORP (0000009326) (Issuer)

    4/7/26 4:56:17 PM ET
    $BCPC
    Major Chemicals
    Industrials

    SVP and GM, Specialty Products Van Gunsteren Job Leonard was granted 1,775 shares and covered exercise/tax liability with 814 shares, increasing direct ownership by 10% to 10,149 units (SEC Form 4)

    4 - BALCHEM CORP (0000009326) (Issuer)

    2/13/26 7:11:01 PM ET
    $BCPC
    Major Chemicals
    Industrials

    SVP Chief Supply Chain Officer Reid Martin Luther was granted 3,299 shares and covered exercise/tax liability with 1,201 shares, increasing direct ownership by 30% to 9,073 units (SEC Form 4)

    4 - BALCHEM CORP (0000009326) (Issuer)

    2/13/26 7:05:59 PM ET
    $BCPC
    Major Chemicals
    Industrials

    $BCPC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026

    MONTVALE, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the Wells Fargo Industrials Conference on June 10, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest qua

    5/27/26 7:00:00 AM ET
    $BCPC
    Major Chemicals
    Industrials

    Balchem Corporation Reports First Quarter 2026 Financial Results

    MONTVALE, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) reported today financial results for its 2026 fiscal first quarter ended March 31, 2026. For the quarter, the Company reported net sales of $270.7 million, net earnings of $40.3 million, adjusted EBITDA(a) of $74.3 million, and free cash flow(a) of $33.8 million. Ted Harris, Chairman, President and CEO of Balchem said, "The first quarter was an excellent start to the year for Balchem, with sales and earnings growth in all three segments. We delivered record first quarter net sales, adjusted EBITDA, and net earnings, as well as strong cash flows." First Quarter 2026 Financial Highlights: Net sales were $

    4/30/26 7:00:00 AM ET
    $BCPC
    Major Chemicals
    Industrials

    Balchem Corporation Releases 2025 Sustainability Report

    MONTVALE, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today published its 2025 Sustainability Report. Our 2025 Sustainability Report centers on the areas where Balchem can create the most meaningful impact and offers a clear, actionable view of our ongoing sustainability journey. The priority topics addressed in the report were identified through continuous engagement with a broad range of internal and external stakeholders, enabling us to understand their sustainability interests and concerns. "I am pleased with the progress Balchem continues to make in advancing our broad-based sustainability efforts, as detailed in our 2025 Sustainability Report." said T

    4/22/26 7:10:17 AM ET
    $BCPC
    Major Chemicals
    Industrials

    $BCPC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rothschild & Co Redburn initiated coverage on Balchem with a new price target

    Rothschild & Co Redburn initiated coverage of Balchem with a rating of Neutral and set a new price target of $162.00

    12/5/25 8:39:34 AM ET
    $BCPC
    Major Chemicals
    Industrials

    HC Wainwright & Co. reiterated coverage on Balchem with a new price target

    HC Wainwright & Co. reiterated coverage of Balchem with a rating of Buy and set a new price target of $155.00 from $170.00 previously

    3/8/22 6:19:56 AM ET
    $BCPC
    Major Chemicals
    Industrials

    Balchem upgraded by Sidoti with a new price target

    Sidoti upgraded Balchem from Neutral to Buy and set a new price target of $175.00

    2/22/22 8:56:13 AM ET
    $BCPC
    Major Chemicals
    Industrials

    $BCPC
    SEC Filings

    View All

    SEC Form 10-Q filed by Balchem Corporation

    10-Q - BALCHEM CORP (0000009326) (Filer)

    4/30/26 4:33:55 PM ET
    $BCPC
    Major Chemicals
    Industrials

    Balchem Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - BALCHEM CORP (0000009326) (Filer)

    4/30/26 7:34:58 AM ET
    $BCPC
    Major Chemicals
    Industrials

    SEC Form SCHEDULE 13G filed by Balchem Corporation

    SCHEDULE 13G - BALCHEM CORP (0000009326) (Subject)

    4/29/26 5:10:38 PM ET
    $BCPC
    Major Chemicals
    Industrials

    $BCPC
    Leadership Updates

    Live Leadership Updates

    View All

    AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directors

    BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. ("AzurRx" or the "Company") (NASDAQ:AZRX), a company specializing in the development of targeted non-systemic, therapies for gastrointestinal (GI) diseases, today announced the appointment of Terry Coelho to its Board of Directors effective immediately. The appointment increases the size of AzurRx's Board to seven members. Ms. Coelho currently serves as the Executive Vice President and Chief Financial Officer at BioDelivery Sciences International, Inc. (NASDAQ:BDSI), a commercial-stage specialty pharmaceutical company. During her more than 30-year career, Ms. Coelho has held numerous senior level financial an

    8/16/21 8:00:00 AM ET
    $AZRX
    $BCPC
    $BDSI
    Major Pharmaceuticals
    Health Care
    Major Chemicals
    Industrials

    $BCPC
    Financials

    Live finance-specific insights

    View All

    Balchem Corporation Reports First Quarter 2026 Financial Results

    MONTVALE, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) reported today financial results for its 2026 fiscal first quarter ended March 31, 2026. For the quarter, the Company reported net sales of $270.7 million, net earnings of $40.3 million, adjusted EBITDA(a) of $74.3 million, and free cash flow(a) of $33.8 million. Ted Harris, Chairman, President and CEO of Balchem said, "The first quarter was an excellent start to the year for Balchem, with sales and earnings growth in all three segments. We delivered record first quarter net sales, adjusted EBITDA, and net earnings, as well as strong cash flows." First Quarter 2026 Financial Highlights: Net sales were $

    4/30/26 7:00:00 AM ET
    $BCPC
    Major Chemicals
    Industrials

    Balchem Corporation Announces Quarterly Conference Call for First Quarter 2026 Financial Results on April 30, 2026

    MONTVALE, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Thursday, April 30, 2026, at 11:00 AM Eastern Time (ET) to review first quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. First quarter results will be published prior to the market opening on Thursday, April 30, 2026. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. Institutional investors, analysts and other members of the financial community are invited to join the live call by

    4/16/26 7:00:00 AM ET
    $BCPC
    Major Chemicals
    Industrials

    Balchem Corporation Reports Fourth Quarter and Full Year 2025 Financial Results

    MONTVALE, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) reported today financial results for its 2025 fiscal fourth quarter and full year ended December 31, 2025. For the quarter, the Company reported net sales of $263.6 million, net earnings of $39.2 million, adjusted EBITDA(a) of $67.9 million, and free cash flow(a) of $51.2 million. For the full year 2025, the Company reported net sales of $1.037 billion, net earnings of $154.8 million, adjusted EBITDA of $274.9 million, and free cash flow of $173.6 million. Ted Harris, Chairman, President, and CEO of Balchem said, "In the fourth quarter, Balchem's strong growth trajectory continued. We delivered record fo

    2/20/26 7:12:32 AM ET
    $BCPC
    Major Chemicals
    Industrials

    $BCPC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Balchem Corporation

    SC 13G/A - BALCHEM CORP (0000009326) (Subject)

    11/13/24 6:56:07 PM ET
    $BCPC
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Balchem Corporation (Amendment)

    SC 13G/A - BALCHEM CORP (0000009326) (Subject)

    2/13/24 4:59:02 PM ET
    $BCPC
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Balchem Corporation (Amendment)

    SC 13G/A - BALCHEM CORP (0000009326) (Subject)

    2/9/24 11:29:17 AM ET
    $BCPC
    Major Chemicals
    Industrials